Environment-sensitive polymers for ophthalmic drug delivery

Journal of Drug Delivery Science and Technology

Volumn 22, Issue 2, 2012, Pages 117-124

  Thrimawithana, T R ^a,b   Rupenthal, I D ^b   Young, S A ^a,b   Alany, R G ^b,c  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

In situ gelling; Ophthalmic drug delivery; Stimuli responsive polymers

Indexed keywords

ADRENALIN; ARTIFICIAL TEAR; BAICALIN; BION; BRINZOLAMIDE; CALCIUM ALGINATE; CARBOMER; CARBOPOL 980; CARBOXYMETHYLCELLULOSE; CARRAGEENAN; CELLACEFATE; CIPROFLOXACIN; DEXTRAN 70; GELLAN; GELRITE; GENTEAL; GLYCEROL; HEMICELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; INDOMETACIN; ION; KELCOGEL; MACROGOL; METHAZOLAMIDE; METHYLCELLULOSE; PILOCARPINE; POLOXAMER; POLY(ETHYLENE GLYCOL)DIACRYLATE; POLY(N ISOPROPYLACRYLAMIDE); POLYCAPROLACTONE; POLYGEL; POLYGLACTIN; POLYMER; REFRESH LIQUIGEL; THERA TEAR; THERA TEAR LIQUIGEL; TIMOLOL; TIMOLOL MALEATE; UNCLASSIFIED DRUG; XYLOGLUCAN;

DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUTION; EYE; EYE DISEASE; GEL; GLAUCOMA; LIGHT; LIQUID; NONHUMAN; OPHTHALMIC DRUG DELIVERY; PH; REVIEW; ROOM TEMPERATURE; SUSTAINED DRUG RELEASE;

EID: 84859633973     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(12)50015-8     Document Type: Review

References (97)

1. Klouda L., Mikos A.G. - Thermoresponsive hydrogels in biomedical applications. - Eur. J. Pharm. Biopharm., 68 (1), 34-45, 2008.
2. Ruel-Gariépy E., Leroux J.C. - In situ-forming hydrogels, Review of temperature-sensitive systems. - Eur. J. Pharm. Biopharm., 58 (2), 409-426, 2004. (Pubitemid 39037244)
3. Afouna M.I., Khedr A., Al-Marzoqi A. - Effects of (-)-carveol and HPMC on the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide formulations in normotensive New Zealand rabbits. - Drug Dev. Res., 70 (3), 191-198, 2009.
4. Wang S.L., Jiang T.Y., Sun C.S., Wang T.Y., Li D.X., Ito Y., Nie S.F., Pan W.S. - Permeability and anticataract effects of a topical ocular drug delivery system of disulfiram. - J. Drug Delivery Sci. Technol., 18 (4), 285-291, 2008.
5. Kaur I.P., Singh M., Kanwar M. - Formulation and evaluation of ophthalmic preparations of acetazolamide. - Int. J. Pharm., 199 (2), 119-127, 2000. (Pubitemid 30236183)
6. Chrai S.S., Robinson J.R. - Ocular evaluation of methylcellulose vehicle in albino rabbits. - J. Pharm. Sci., 63 (8), 1218-1223, 1974.
7. Sasaki H., Yamamura K., Mukai T., Nishida K., Nakamura J., Nakashima M., Ichikawa M. - Pharmacokinetic prediction of the ocular absorption of an instilled drug with ophthalmic viscous vehicle. - Biol. Pharm. Bull., 23 (11), 1352-1356, 2000.
8. Kundu P.P., Kundu M. - Effect of salts and surfactant and their doses on the gelation of extremely dilute solutions of methyl cellulose. - Polymer, 42 (5), 2015-2020, 2001. (Pubitemid 33717715)
9. Xu Y., Wang C., Tarn K.C., Li L. - Salt-assisted and salt-suppressed sol-gel transitions of methylcellulose in water. - Langmuir, 20 (3), 646-652, 2004.
10. Sarkar N. - Thermal gelation properties of methyl and hydroxypropyl methylcellulose. - J. Appl. Polym. Sci., 24 (4), 1073-1087, 1979. (Pubitemid 9475816)
11. Xu Y., Li L., Zheng P., Lam Y.C., Hu X. - Controllable gelation of methylcellulose by a salt mixture. - Langmuir, 20, 6134-6138, 2004.
12. Hirrien M., Chevillard C., Desbrières J., Axelos M.A.V., Rinaudo M. - Thermogelation of methylcelluloses: new evidence for understanding the gelation mechanism. - Polymer, 39 (25), 6251-6259, 1998. (Pubitemid 128370026)
13. Bain M.K., Bhowmik M., Ghosh S.N., Chattopadhyay D. - In situ fast gelling formulation of methyl cellulose for in vitro ophthalmic controlled delivery of ketorolac tromethamine. - J. Appl. Polym. Sci., 113 (2), 1241-1246, 2009.
14. Bhowmik M., Bain M.K., Ghosh L.K., Chattopadhyay D. - Effect of salts on gelation and drug release profiles of methylcellulose-based ophthalmic thermo-reversible in situ gels. - Pharm. Dev. Technol., 16 (4), 385-391, 2011.
15. Mishra A., Malhotra A. - Tamarind xyloglucan: a polysaccharide with versatile application potential. - J. Mater. Chem., 19, 8528-8536, 2009.
16. Nisbet D.R., Crompton K.E., Hamilton S.D., Shirakawa S., Prankerd R.J., Finkelstein D.I., Horne M.K., Forsythe J.S. - Morphology and gelation of thermosensitive xyloglucan hydrogels. - Biophys. Chem., 121 (1), 14-20, 2006.
17. Shirakawa M., Yamatoya K., Nishinari K. Tailoring of xyloglucan properties using an enzyme. - Food Hydrocolloids, 12 (1), 25-28, 1998.
18. Miyazaki S., Suzuki S., Kawasaki N., Endo K., Takahashi A., Attwood D. - In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride. - Int. J. Pharm., 229 (1-2), 29-36, 2001. (Pubitemid 32972078)
19. Ghelardi E., Tavanti A., Davini P., Celandroni F., Salvent S., Parisio E., Boldrini E., Senesi S., Campa M. - A mucoadhesive polymer extracted from tamarind seed improves the intraocular penetration and efficacy of rufloxacin in topical treatment of experimental bacterial keratitis. - Antimicrob. Agents Chemother., 48 (9), 3396-3401, 2004. (Pubitemid 39129336)
20. Alexandridis P, Alan Hatton T. - Poly (ethylene oxide)poly (propylene oxide)poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling. - Colloids Surf., A, 96 (1-2), 1-46, 1995.
21. Fusco S., Borzacchiello A., Netti P.A. - Perspectives on: PEO-PPO-PEO triblock copolymers and their biomedical applications. - J. Bioact. Compat. Polym., 21 (2), 149-164, 2006. (Pubitemid 43260606)
22. Miyazaki S., Takeuchi S., Yokouchi C., Takada M. - Pluronic F-127 gels as a vehicle for topical administration of anticancer agents. - Chem. Pharm. Bull., 32 (10), 4205-4208, 1984. (Pubitemid 15208373)
23. Johnston TR, Miller S.C. - Inulin disposition following intramuscular administration of an inulin/poloxamer gel matrix. - J. Parenter. Sci. Technol., 43 (6), 279-286, 1989. (Pubitemid 20028934)
24. Katakam M., Ravis W.R., Banga A.K. - Controlled release of human growth hormone in rats following parenteral administration of poloxamer gels. - J. Controlled Release, 49 (1), 21-26, 1997. (Pubitemid 27417897)
25. Mohamed F.A. - Transdermal delivery of diclofenac sodium from Pluronic and other conventional formulations. - STP Pharma, 5 (6), 456-460, 1995. (Pubitemid 26033791)
26. Barichello J.M., Morishita M., Takayama K., Chiba Y, Tokiwa S., Nagai T. - Enhanced rectal absorption of insulin-loaded Pluronic F-127 gels containing unsaturated fatty acids. - Int. J. Pharm., 183 (2), 125-132, 1999. (Pubitemid 29257958)
27. Ryu J.M., Chung S.J., Lee M.H., Kim C.K., Shim C.H.- Increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum. - J. Controlled Release, 59 (2), 163-172, 1999.
28. Kim Y.T., Shin B.K., Garripelli V.K., Kim J.K., Davaa E., Jo S., Park J.S. - A thermosensitive vaginal gel formulation with HPγCD for the pH-dependent release and solubilization of amphotericin B. - Eur. J. Pharm. Sci., 41 (2), 399-406, 2010.
29. Bilensoy E., Rouf M.A., Vural I., Sen M., Hincal A.A. Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole: β-cyclodextrin complex. - AAPS PharmSciTech, 7 (2), 2006.
30. Miller S.C., Donovan M.D. - Effect of poloxamer 407 gel on the miotic activity of pilocarpine nitrate in rabbits. - Int. J. Pharm., 12 (2-3), 147-152, 1982. (Pubitemid 12037338)
31. Vehanen K., Hornof M., Urtti A., Uusitalo H. - Peribulbar poloxamer for ocular drug delivery. - Acta Ophthalmol., 86 (1), 91-96, 2008. (Pubitemid 351512477)
32. Desai S.D., Blanchard J. - Evaluation of Pluronic F127-based sustained-release ocular delivery systems for pilocarpine using the albino rabbit eye model. - J. Pharm. Sci., 87 (10), 1190-1195, 1998. (Pubitemid 28455607)
33. El-Kamel A.H. - In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system fortimolol maleate. - Int. J. Pharm., 241 (1), 47-55, 2002. (Pubitemid 34667065)
34. Mansour M., Mansour S., Mortada N.D., Abd ElHady S.S. - Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels. - Drug Dev. Ind. Pharm., 34 (7), 744-752, 2008. (Pubitemid 351962350)
35. Qian Y., Wang F, Li R., Zhang Q., Xu Q. - Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide. - Drug Dev. Ind. Pharm., 36 (11), 1340-1347, 2010.
36. Heskins M., Guillet J.E. - Solution properties of poly (N-isopro-pylacrylamide). - J. Macromol. Sci., 2, 1441-1455, 1968.
37. Schild H.G. - Poly(N-isopropylacrylamide): experiment, theory and application. - Prog. Polym. Sci., 17 (2), 163-249, 1992.
38. Kang Derwent J.J., Mieler W.F. - Thermoresponsive hydrogels as a new ocular drug delivery platform to the posterior segment of the eye. -Trans. Am. Ophthalmol. Soc., 106, 206-213, 2008.
39. Hsiue G.H., Hsu S.H., Yang C.C., Lee S.H., Yang I.K. - Preparation of controlled release ophthalmic drops, for glaucoma therapy using thermosensitive poly-N-isopropylacrylamide. - Biomaterials, 23 (2), 457-462, 2002.
40. Cao Y., Zhang C., Shen W., Cheng Z., Yu L., Ping Q. - Poly (N-isopropylacrylamide)-chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. - J. Controlled Release, 120 (3), 186-194, 2007. (Pubitemid 47058641)
41. Knop K., Hoogenboom R., Fischer D., Schubert U.S. - Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. - Angew. Chem., Int. Ed., 49 (36), 6288-6308, 2010.
42. Fredenberg S., Wahlgren M., Reslow M., Axelsson A. - The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems, A review. - Int. J. Pharm., 415 (1-2), 34-52, 2011.
43. Jeong B., Bae Y.H., Kim S.W. - Thermoreversible gelation of PEG-PLGA-PEG triblock copolymer aqueous solutions. - Macromolecules, 32 (21), 7064-7069, 1999. (Pubitemid 32079730)
44. Zentner G.M., Rathi R., Shih C., McRea J.C., Seo M.H., Oh H., Rhee B.G., Mestecky J., Moldoveanu Z., Morgan M., Weitman S. - Biodegradable block copolymers for delivery of proteins and water-insoluble drugs. - J. Controlled Release, 72 (1-3), 203-215, 2001. (Pubitemid 32522358)
45. Gao Y., Sun Y., Ren F., Gao S. - PLGA-PEG-PLGA hydrogel for ocular drug delivery of dexamethasone acetate. - Drug Dev. Ind. Pharm., 36 (10), 1131-1138, 2010.
46. Pratoomsoot C., Tanioka H., Hori K., Kawasaki S., Kinoshita S., Tighe P.J., Dua H., Shakesheff K.M., Rose F.R.A.J. - A thermoreversible hydrogel as a biosynthetic bandage for corneal wound repair. - Biomaterials, 29 (3), 272-281, 2008.
47. Dash T.K. - Poly-ε-caprolactone based formulations for drug delivery and tissue engineerings review. - J. Controlled Release, 2012.10.1016/j. jconrel.2011.09.064,
48. Wei X., Gong C., Gou M., Fu S., Guo Q., Shi S., Luo F., Guo G., Qiu L., Qian Z. - Biodegradable poly(ε-caprolactone)-poly(ethylene glycol) copolymers as drug delivery system. - Int. J. Pharm., 381 (1), 1-18, 2009.
49. Martini L., Artwood D., Collert J.H., Nicholas C.V., Tanodekaew S., Deng N., Heatley F., Booth C. - Micellisation and gelation of triblock copolymer of ethylene oxide and ε-caprolactone, CLnEmCLn, in aqueous solution. - J. Chem. Soc., Faraday Trans., 90 (13), 1961-1966, 1994.
50. Liu C.B., Gong C.Y., Huang M.J., Wang J.W., Pan Y.F., Zhang Y.D., Li G.Z., Gou M.L., Wang K., Tu M.J., Wei Y.Q., Qian Z.Y. - Thermoreversible gel-sol behavior of biodegradable PCL-PEG-PCL triblock copolymer in aqueous solutions. - J. Biomed. Mater. Res., Part B, 84 (1), 165-175, 2008.
51. Gong C.Y., Dong P.W., Shi S., Fu S.Z., Yang J.L., Guo G., Zhao X., Wei Y.Q., Qian Z.Y. - Thermosensitive PEG-PCL-PEG hydrogel controlled drug delivery system: sol-gel-sol transition and in vitro drug release study. - J. Pharm. Sci., 98 (10), 3707-3717, 2009.
52. Mishra G.P., Tamboli V., Mitra A.K. - Effect of hydrophobic and hydrophilic additives on sol-gel transition and release behavior of timolol maleate from polycaprolactone-based hydrogel. - Colloid Polym. Sci., 289 (14), 1553-1562, 2011.
53. Beeley N.R.F., Rossi J.V., Mello-Filho P.A.A., Mahmoud M.I., Fujii G.Y., De Juan Jr E., Varner S.E. - Fabrication, implantation, elution, and retrieval of a steroid-loaded polycaprolactone subretinal implant. - J. Biomed. Mater. Res., Part A, 73 (4), 437-444, 2005. (Pubitemid 40791391)
54. Carcaboso A.M., Chiappetta D.A., Opezzo J.A.W., Hocht C., Fandiñ A.C., Croxatto J.O., Rubio M.C., Sosnik A., Abramson D.H., Bramuglia G.F., Chantada G.L. - Episcleral implants for topotecan delivery to the posterior segment of the eye. - Invest. Ophthalmol. Visual Sci., 51 (4), 2126-2134, 2010.
55. Schmaljohann D. - Thermo- and pH-responsive polymers in drug delivery. - Adv. Drug Delivery Rev., 58 (15), 1655-1670, 2006. (Pubitemid 44830149)
56. Bawa P., Pillay V., Choonara Y.E., DuToit L.C. - Stimuli-responsive polymers and their applications in drug delivery. - Biomed. Mater., 4 (2), 2009.
57. Singla A.K., Chawla M., Singh A. - Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: a review. - Drug Dev. Ind. Pharm., 26 (9), 913-924, 2000. (Pubitemid 30471037)
58. Mundada A.S., Avari J.G. - In situ gelling polymers in ocular drug delivery systems: a review. - Crit. Rev. Ther. Drug Carrier Syst., 26(1), 85-118, 2009.
59. Charoo N.A., Kohli K., Ali A. - Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: In vitro and in vivo studies. - J. Pharm. Sci., 92 (2), 407-413, 2003. (Pubitemid 36169313)
60. Al-Kassas R.S., El-Khatib M.M. - Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers. - Drug Delivery, 16 (3), 145-152, 2009.
61. Parthiban K.G., Manivannan R., Kumar B.S., Ahasan M.B. - Formulation and evaluation of ketorolac ocular pH-triggered in situ gel. - Int. J. Drug Dev. Res., 2 (3), 459-467, 2010.
62. Srividya B., Cardoza R.M., Amin P.D. - Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system.- J. Controlled Release, 73 (2-3), 205-211, 2001. (Pubitemid 32539249)
63. Edsman K., Carlfors J., Harju K. - Rheological evaluation and ocular contact time of some carbomer gels for ophthalmic use. - Int. J. Pharm., 137 (2), 233-241, 1996. (Pubitemid 26226075)
64. Ayers D., Cuthbertson J.M., Schroyer K., Sullivan S.M. - Polyacrylic acid mediated ocular delivery of ribozymes. - J. Controlled Release, 38 (2-3), 167-175, 1996. (Pubitemid 26097592)
65. Wu H., Liu Z., Peng J., Li L., Li N., Li J., Pan H. - Design and evaluation of baicalin-containing in situ pH-triggered gelling system for sustained ophthalmic drug delivery. - Int. J. Pharm., 410 (1-2), 31-40, 2011.
66. Debbasch C., De La Salle S.B., Brignole F., Rat P., Warnet J.M., Baudouin C. - Cytoprotective effects of hyaluronic acid and carbomer 934P in ocular surface epithelial cells. - Invest. Ophthalmol. Visual Sci., 43 (11), 3409-3415, 2002. (Pubitemid 35334347)
67. Johnson M.E., Murphy P.J., Boulton M. - Carbomer and sodium hyaluronate eyedrops for moderate dry eye treatment. - Optometry and Vision Science, 85 (8), 750-757, 2008.
68. Ibrahim H., Bindschaedler C., Doelker E., Buri P., Gurny R. - Concept and development of ophthalmic pseudo-latexes triggered by pH. - Int. J. Pharm., 77 (2-3), 211-219, 1991.
69. Gurny R., Ibrahim H., Aebi A., Buri P., Wilson C.G., Washington N., Edman P., Camber O. - Design and evaluation of controlled release systems for the eye. - J. Controlled Release, 6 (Spec. No.), 367-373, 1987.
70. Kesavan K., Balasubramaniam J., Kant S., Singh P.N., Pandit J.K. - Newer approaches for optimal bioavailability of ocularly delivered drugs: review. - Curr. Drug Delivery, 8 (2), 172-193, 2011.
71. Vyast S.P., Ramchandraiah S., Jain C.P., Jain S.K. - Polymeric pseudolatices bearing pilocarpine for controlled ocular delivery. - J. Microencapsulation, 9 (3), 347-355, 1992.
72. Giavasis I., Harvey L.M., McNeil B. - Gellan gum. - Crit. Rev. Biotechnol., 20 (3), 177-211, 2000.
73. Robinson G., Manning C.E., Morris E.R. - Conformation and physical properties of the bacterial polysaccharides gellan, welan and rhamsan. - In: Food Polymers, Gels, and Colloids, E. Dickinson Ed., Royal Society Chemistry, London, 1991, p. 22-33.
74. Rozier A., Mazuel C., Grove J., Plazonnet B. - Gelrite: a novel, ion-activated, in situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. - Int. J. Pharm., 57 (2), 163-168, 1989. (Pubitemid 20011840)
75. Balasubramaniam J., Kumar M.T., Pandit J.K., Kant S. - Gellan-based scleral implants of indomethacin: in vitro and in vivo evaluation. - Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents, 11 (6), 371-379, 2004. (Pubitemid 39578596)
76. Balasubramaniam J., Kant S., Pandit J.K. - In vitro and in vivo evaluation of the Gelrite gellan gum-based ocular delivery system for indomethacin. - Acta Pharm., 53 (4), 251-261, 2003. (Pubitemid 38083940)
77. Balasubramaniam J., Pandit J.K. - Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride. - Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents, 10 (3), 185-191, 2003. (Pubitemid 36993370)
78. Sultana Y., Aqil M., Ali A. - Ion-activated, Gelrite-based in situ ophthalmic gels of Pefloxacin mesylate: comparison with conventional eye drops. - Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents, 13 (3), 215-219, 2006.
79. Tønnesen H.H., Karlsen J. - Alginate in drug delivery systems. - Drug Dev. Ind. Pharm., 28 (6), 621-630, 2002.
80. Coviello T., Matricardi P., Marianecci C., Alhaique F. - Polysaccharide hydrogels for modified release formulations. - J. Controlled Release, 119 (1), 5-24, 2007. (Pubitemid 46561537)
81. Cohen S., Lobel E., Trevgoda A., Peled Y. - A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye. - J. Controlled Release, 44 (2-3), 201-208, 1997. (Pubitemid 27039116)
82. Séchoy O., Tissié G., Sébastian C., Maurin F., Driot J.Y., Trinquand C. - A new long acting ophthalmic formulation of Carteolol containing alginic acid. - Int. J. Pharm., 207 (1-2), 109-116, 2000.
83. Hassan M.A. - A long acting ophthalmic gel formulations of atenolol. - Drug Dev. Ind. Pharm., 33 (11), 1192-1198, 2007. (Pubitemid 350208741)
84. Pandya T.P., Modasiya M.K., Patel V.M. - Sustained ophthalmic delivery of ciprofloxacin hydrochloride from an ion-activated in situ gelling system. - Der Pharm. Lett., 3 (3), 404-410, 2011.
85. Rupenthal I.D., Green C.R., Alany R.G. - Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study. - Int. J. Pharm., 411 (1-2), 78-85, 2011.
86. Qiu Y., Park K. - Environment-sensitive hydrogels for drug delivery. - Adv. Drug Delivery Rev., 53 (3), 321-339, 2001.
87. Mamada A., Tanaka T., Kungwatchakun D., Irie M. - Photoinduced phase transition of gels. - Macromolecules, 23 (5), 1517-1519, 1990.
88. Suzuki A., Tanaka T. - Phase transition in polymer gels induced by visible light. - Nature, 346 (6282), 345-347, 1990.
89. Wells L.A. - Photoresponsive drug delivery from anthracene-modified hydrogels. - ETD Collection for McMaster University, Paper AAINR74085, 2011.
90. Shastri D.H., Patel L.D., Parikh R.K.- Studies on in situ hydrogel: a smart way for safe and sustained ocular drug delivery. - J. Young Pharm., 2 (2), 116-120, 2010.
91. Lin H.R., Sung K.C., Vong W.J. - In situ gelling of alginate/Pluronic solutions for ophthalmic delivery of pilocarpine. - Biomacromolecules, 5 (6), 2358-2365, 2004. (Pubitemid 39585290)
92. Lin H.R., Sung K.C. - Carbopol/pluronic phase change solutions for ophthalmic drug delivery. - J. Controlled Release, 69 (3), 379-388, 2000.
93. Gupta H., Velpandian T., Jain S. - Ion-and pH-activated novel in-situ gel system for sustained ocular drug delivery. - J. Drug Targeting, 18 (7), 499-505, 2010.
94. Gupta H., Jain S., Mathur R., Mishra P., Mishra A.K., Velpandian T. - Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. - Drug Delivery, 14 (8), 507-515, 2007. (Pubitemid 350135850)
95. Gratieri T., Gelfuso G.M., Rocha E.M., Sarmento V.H., de Freitas O., Lopez R.F.V. - A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. - Eur. J. Pharm. Biopharm., 75 (2), 186-193, 2010.
96. Thrimawithana T.R., Young S.A., Bunt C.R., Green C.R., Alany R.G. - In vitro and in vivo evaluation of carrageenan/methylcellulose polymeric systems for transscleral delivery of macromolecules. - Eur. J. Pharm. Sci., 44, 399-409, 2011.
97. Thrimawithana T.R., Young S.A., Dunstan D.E., Alany R.G. - Texture and rheological characterization of kappa and iota carrageenan in the presence of counter ions. - Carbohydr. Polym., 82, 69-77, 2010.